Clinical trial

Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia

NCT03212456

Drugs and interventions used in this trial

4 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention opioid-free group Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Opioid Group Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention transversus abdominal plane block with ropivacaine Find medicine records · Find other trials using this name

PROCEDURE · Unmapped registry intervention transversus abdominal plane block with placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Evaluation of Post-operative Biochemical Recurrence in Patients Submitted to Radical Prostatectomy Under General Opioid-free Anesthesia Compared to Conventional General Anesthesia

Design: INTERVENTIONAL · Status: UNKNOWN · Phase: NA

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2017-01-12

PhaseNA

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Interventions

opioid-free groupDRUG

Opioid GroupDRUG

transversus abdominal plane block with ropivacainePROCEDURE

transversus abdominal plane block with placeboPROCEDURE

Sponsors & collaborators

Instituto do Cancer do Estado de São Paulolead sponsor

Mapped research locations

São PauloSão Paulo, Brazil1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03212456 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.